644 related articles for article (PubMed ID: 11397650)
1. Mutations in apoptosis genes: a pathogenetic factor for human disease.
Müllauer L; Gruber P; Sebinger D; Buch J; Wohlfart S; Chott A
Mutat Res; 2001 Jul; 488(3):211-31. PubMed ID: 11397650
[TBL] [Abstract][Full Text] [Related]
2. Expression of apoptosis-related proteins, p53, and DNA fragmentation in sarcomas of the pulmonary artery.
Gaumann A; Tews DS; Mayer E; Dahm M; Petrow PK; Otto M; Kirkpatrick CJ; Kriegsmann J
Cancer; 2001 Sep; 92(5):1237-44. PubMed ID: 11571738
[TBL] [Abstract][Full Text] [Related]
3. Transfection of caspase-3 in the caspase-3-deficient Hodgkin's disease cell line, KMH2, results in enhanced sensitivity to CD95-, TRAIL-, and ARA-C-induced apoptosis.
Wrone-Smith T; Izban KF; Ergin M; Cosar EF; Hsi ED; Alkan S
Exp Hematol; 2001 May; 29(5):572-81. PubMed ID: 11376869
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Fas ligand-induced apoptosis by TNF.
Elzey BD; Griffith TS; Herndon JM; Barreiro R; Tschopp J; Ferguson TA
J Immunol; 2001 Sep; 167(6):3049-56. PubMed ID: 11544288
[TBL] [Abstract][Full Text] [Related]
5. Apoptosis in acute shigellosis is associated with increased production of Fas/Fas ligand, perforin, caspase-1, and caspase-3 but reduced production of Bcl-2 and interleukin-2.
Raqib R; Ekberg C; Sharkar P; Bardhan PK; Zychlinsky A; Sansonetti PJ; Andersson J
Infect Immun; 2002 Jun; 70(6):3199-207. PubMed ID: 12011015
[TBL] [Abstract][Full Text] [Related]
6. Gender and androgen treatment influence the expression of proto-oncogenes and apoptotic factors in lacrimal and salivary tissues of MRL/lpr mice.
Toda I; Wickham LA; Sullivan DA
Clin Immunol Immunopathol; 1998 Jan; 86(1):59-71. PubMed ID: 9434797
[TBL] [Abstract][Full Text] [Related]
7. DAP-kinase participates in TNF-alpha- and Fas-induced apoptosis and its function requires the death domain.
Cohen O; Inbal B; Kissil JL; Raveh T; Berissi H; Spivak-Kroizaman T; Feinstein E; Kimchi A
J Cell Biol; 1999 Jul; 146(1):141-8. PubMed ID: 10402466
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).
Umansky V; Ushmorov A; Ratter F; Chlichlia K; Bucur M; Lichtenauer A; Rocha M
Int J Oncol; 2000 Jan; 16(1):109-17. PubMed ID: 10601555
[TBL] [Abstract][Full Text] [Related]
9. Differential involvement of the CD95 (Fas/APO-1) receptor/ligand system on apoptosis induced by the wild-type p53 gene transfer in human cancer cells.
Fukazawa T; Fujiwara T; Morimoto Y; Shao J; Nishizaki M; Kadowaki Y; Hizuta A; Owen-Schaub LB; Roth JA; Tanaka N
Oncogene; 1999 Apr; 18(13):2189-99. PubMed ID: 10327065
[TBL] [Abstract][Full Text] [Related]
10. In the erythroleukemic cell line HEL Prostate-apoptosis-response-gene-4 (par-4) fails to down-regulate Bcl-2 and to promote apoptosis.
Boehrer S; Brieger A; Schaaf S; Kukoc-Zivojnov N; Nowak D; Ruthardt M; Hoelzer D; Mitrou PS; Weidmann E; Chow KU
Leuk Lymphoma; 2004 Jul; 45(7):1445-51. PubMed ID: 15359646
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis induced by DNA damage O6-methylguanine is Bcl-2 and caspase-9/3 regulated and Fas/caspase-8 independent.
Ochs K; Kaina B
Cancer Res; 2000 Oct; 60(20):5815-24. PubMed ID: 11059778
[TBL] [Abstract][Full Text] [Related]
12. Tissue specific expression of p53 target genes suggests a key role for KILLER/DR5 in p53-dependent apoptosis in vivo.
Burns TF; Bernhard EJ; El-Deiry WS
Oncogene; 2001 Aug; 20(34):4601-12. PubMed ID: 11498783
[TBL] [Abstract][Full Text] [Related]
13. Signalling apoptosis: a radical approach.
Carmody RJ; Cotter TG
Redox Rep; 2001; 6(2):77-90. PubMed ID: 11450987
[TBL] [Abstract][Full Text] [Related]
14. The c-Myc-interacting adaptor protein Bin1 activates a caspase-independent cell death program.
Elliott K; Ge K; Du W; Prendergast GC
Oncogene; 2000 Sep; 19(41):4669-84. PubMed ID: 11032017
[TBL] [Abstract][Full Text] [Related]
15. Inherited human Caspase 10 mutations underlie defective lymphocyte and dendritic cell apoptosis in autoimmune lymphoproliferative syndrome type II.
Wang J; Zheng L; Lobito A; Chan FK; Dale J; Sneller M; Yao X; Puck JM; Straus SE; Lenardo MJ
Cell; 1999 Jul; 98(1):47-58. PubMed ID: 10412980
[TBL] [Abstract][Full Text] [Related]
16. In vitro apoptosis and expression of apoptosis-related molecules in lymphocytes from patients with systemic lupus erythematosus and other autoimmune diseases.
Lorenz HM; Grünke M; Hieronymus T; Herrmann M; Kühnel A; Manger B; Kalden JR
Arthritis Rheum; 1997 Feb; 40(2):306-17. PubMed ID: 9041943
[TBL] [Abstract][Full Text] [Related]
17. p53 enhances BAK and CD95 expression in human malignant glioma cells but does not enhance CD95L-induced apoptosis.
Pohl U; Wagenknecht B; Naumann U; Weller M
Cell Physiol Biochem; 1999; 9(1):29-37. PubMed ID: 10352342
[TBL] [Abstract][Full Text] [Related]
18. Role of complement-binding CD21/CD19/CD81 in enhancing human B cell protection from Fas-mediated apoptosis.
Mongini PK; Jackson AE; Tolani S; Fattah RJ; Inman JK
J Immunol; 2003 Nov; 171(10):5244-54. PubMed ID: 14607925
[TBL] [Abstract][Full Text] [Related]
19. The kiss of death: promises and failures of death receptors and ligands in cancer therapy.
Daniel PT; Wieder T; Sturm I; Schulze-Osthoff K
Leukemia; 2001 Jul; 15(7):1022-32. PubMed ID: 11455969
[TBL] [Abstract][Full Text] [Related]
20. Apoptosis induction in prostate cancer cells and xenografts by combined treatment with Apo2 ligand/tumor necrosis factor-related apoptosis-inducing ligand and CPT-11.
Ray S; Almasan A
Cancer Res; 2003 Aug; 63(15):4713-23. PubMed ID: 12907654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
